Nothing comes for free Anthony L. Estrera, MD The Journal of Thoracic and Cardiovascular Surgery Volume 150, Issue 1, Pages 142-144 (July 2015) DOI: 10.1016/j.jtcvs.2015.04.041 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Number of retrograde type A aortic dissections reported per year from 2005 through 2014 to the Food and Drug Administration (FDA) by way of the Manufacturer and User Facility Device Experience (MAUDE) database. (Note that some reports were synopses of recent articles on the topic of retrograde acute type A aortic dissection and were excluded. Only reports that included details of the case submitted, allowing confirmation of retrograde acute type A aortic dissection, were included.) IFU, Indications for use; TEVAR, thoracic endovascular aortic repair. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 142-144DOI: (10.1016/j.jtcvs.2015.04.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions
The Journal of Thoracic and Cardiovascular Surgery 2015 150, 142-144DOI: (10.1016/j.jtcvs.2015.04.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions